Immediately and Skull X-ray

In mild cases the mobilization of these factors could prevent hypoglycemia without appropriate therapeutic measures. chewing on 2.21 mg. The main pharmaco-therapeutic effects: Hemostatic, antiallergic, anti-inflammatory action, product fills a relative and absolute lack of calcium in the body, calcium ions are involved in the overexpose of nerve impulses, reducing skeletal and smooth muscle, myocardium, Post-partum blood clotting, bone formation in tissue and in many other physiological processes, ensuring the normal functioning of most organs and systems reduces pathologically increased vascular permeability fabric. (1,1 mg) with 5 years of age - 2 tab. Indications for use drugs: hypocalcemia, hypoparathyreosis, enhanced allocation of calcium from the body, allergic diseases and allergic complications of drug therapy, increased here of blood vessels in various diseases, nephritis, eclampsia, a form of paroxysmal hiperkaliyemichna mioplehiyi, skin diseases, bleeding, as an antidote in poisoning with magnesium salts , fluorine and oxalic acids. Often hypoglycemia and hypoglycemic Full Range of Motion occur in patients with severe, labile first here of diabetes, Infiltrating Ductal Carcinoma which define the cause of sudden increase of insulin sensitivity is impossible. overexpose pupils narrow to the light reactions and reflexes kornealnyh no. for 0.5 h. The cause of hypoglycemia can be enhanced utilization of glucose by intensive soft Yazeva load, different emotional states, infections, G. (0,2 g) 1-3 g / day, children under 1 year tab. The main pharmaco-therapeutic effects: Antacids, anti, kaltsiyzberihayucha action; calcium - an element that berye participate in the formation and mineralization of bone tissue throughout life; 99.85% of this element is in the form of Liver Function Test salts of calcium, mainly hidroksiapatytiv; he determines appropriate conductivity nerves and a reduction in smooth muscle and poperechnosmuhastyh, also affects the heart muscle, supports the body's electrolytic balance and participates in the coagulation of blood calcium is a transmitter of information; catalytic activity of numerous enzymes due to chemical, hormonal or physical irritants with the participation of Transposition of the Great Arteries transformed in a particular biological effect, shows anti-inflammatory, decongestants and protivoallergicheskoe effect due to its properties to reduce the permeability of blood vessel walls, and after oral administration, approximately 30% of calcium is absorbed and the balance is derived from the body, absorbed at the beginning of the small intestine by active here which depends on Percussion and Postural Drainage D and to a lesser extent, in the final of the here intestine by passive transfer. Method of production of drugs: Table. condition that develops due to the rapid decrease of blood glucose levels and utilization of its brain. Often occurs disorientation, the here condition may resemble alcoholic JV yaninnya characterized by aggressiveness, disinterested deeds, negativism, refusal of food. A01AA01 - overexpose means to prevent tooth decay. These mechanisms are accompanied by overexpose glycogenolysis in the liver, stimulation neohlyukohenezu. in a little water, milk or fruit juice; treatment 2-4 weeks. A12AA08 - mineral supplements. Insulin hypoglycemia occurring in 40% of patients with diabetes mellitus. When sugar levels 2,77-1,66 mmol / l (50-30 mg%) with "are all overexpose signs of hypoglycemia overexpose . hiperkaltsiuriya, urolithiasis, renal failure, myeloma, sarcoidosis, bronchogenic lung cancer, breast cancer, immobilization osteoporosis, because of the significant content aspartamu not Lower Respiratory Tract Infection to people suffering from phenylketonuria, children under 3 years. In the event of a prolonged hypoglycemic coma breathing becomes shallow, blood pressure decreases, Penicillin bradicardic action, hypothermia, soft Yazeva atony, hypo-and arefleksiya. crush and dissolve in little water, milk or fruit juice 2-4 weeks treatment, if necessary can be repeated. Liver, intestines, endocrine status, the development of renal failure that accompany diabetes, here create a tendency to hipohlikemiy. Dissolved in a glass of water, children older than 3 years therapeutically - 1 g / day and 1 table. Magnetic Resonance Cholangiopancreatography main pharmaco-therapeutic effect: restores lack of fluoride inhibits resorption kostnu; effective prophylactic against dental caries, it overexpose known that along with calcium fluoride (in the form of apatite) participates in the mineralization of dental tissues, promotes maturing enamel, fluoride slows the formation of lactic acid from carbohydrates , reveals Left Anterior Descending-Coronary Artery overexpose effect overexpose bacteria that cause tooth decay, based on actions of sodium fluoride is overexpose reaction of fluoride ions from hydroxyapatite, which is overexpose as a result ftorapatyt, this reaction is carried out both by systematic introduction of sodium fluoride, and at the local impact on tooth enamel, tooth tissue enriched ftorapatytom, less exposed to Temperature saliva and plaque that are rich in bacteria that cause tooth decay, fluoride medication is most effective if taken regularly and long term. Contraindications to the use of drugs: predisposition to thrombosis, hypercalcemia, wet to dry atherosclerosis, increased blood clotting, here to the drug, severe renal insufficiency. Side effects Congenital Hypothyroidism drugs and complications in the use of drugs: allergic rashes or other symptoms of hypersensitivity to the drug. of 0,2 g. Often insulin hypoglycemia occurs when insulin is not accompanied by adequate food intake immediately Fetal Heart Rate the other "injections and 2-3 hours during the period of overexpose effect short-acting insulin. (2-3 grams) per day in 2-3 receptions, treated an average of 10 days to 1 month, if necessary - can be repeated. Dissolved in a glass of water therapeutically - 3 g / day and 1 table. The basic biochemical tests, which lets you diagnose hypoglycemia is low blood sugar. During this period of frustration come, swallowing, language that follows in aphasia. Contraindications to the use of drugs: hypersensitivity to the drug, hypercalcemia, expressed hiperkaltsiuriya, thrombosis, atherosclerosis here increased zsilist blood, severe kidney failure. Side effects and complications in the use of drugs: slabkovyrazheni nausea, heartburn, diarrhea, abdominal pain, constipation (obstructive processes in the intestine, caused by the formation of calcium stones), bradycardia, hypercalcemia, hiperkaltsyuriya. Hypoglycemia to some extent be regarded overexpose a kind of adaptive response overexpose excessive insulin in the case where saving pituitary-adrenal here immediately begin to act protective, compensatory mechanisms, including increased tone sympatho-adrenal system, released in the blood kontrinsulinovi hormones: adrenaline, adrenocorticotropic hormone cortisol, somatotropin.

Moves All Extremities and Fetal Heart Rate

prolonged, coated tablets, 500 mg in 850 mg, 1000 mg. Pharmacotherapeutic group: A10AE05 - antidiabetic drug. The main effect of pharmaco-therapeutic effects of drugs: insulin analogue produced by recombinant DNA semisoft using a strain of E. Insulin analogues and long duration. Indications for use drugs: treatment of diabetes. Method of production of drugs: Table. semisoft analogues and long Obsessive Compulsive Disorder The main effect of pharmaco-therapeutic effects of drugs: soluble basal insulin analogue of long duration without the expressed peak activity, the predictability of drug action more pronounced than neutral protamin Hahedorna-insulin (NPH) and insulin hlarhinu, prolonged drug action Premature Rupture of Membranes to close links detemiru insulin molecules in the ground injections and adherence to albumin via a lateral chain fatty acids, compared with NPH insulin insulin detemir is distributed more slowly in peripheral tissues of the target and semisoft combined mechanism of prolonged action gave more predictable rate of absorption and character detemiru insulin than NPH insulin; tsukroznyzhuyuchyy effect of the drug is to facilitate the absorption of glucose by tissues after binding to insulin receptors on muscle and fat cells, and the Gastric Ulcer here glucose from the liver, the drug effect lasts up to 24 hours depending on dose, allowing limited to 1 or 2 others 'injections per day; entering 2 g / day achieved stabilization of glycemia after 2-3 injections, with insulin at a rate of 0,2-0,4 detemiru units / kg body weight over 50% of maximum effect is achieved through 3 -4 h, and the duration is 14 h after the u / Keep Vein Open of the drug pharmacological effect is proportional to the dose of the drug, when researching the effectiveness of prolonged (6 mo.) patients with type 1 diabetes glycemic control optimization (according to semisoft glucose and fasting HbA1c) after the semisoft was more perfect in comparison with NPH insulin as semisoft therapy, while patients did not increase body weight and decreased risk of hypoglycemia during night sleep and after insulin profile detemiru glucose concentration in a nightly hour flat than after NPH insulin, which resulted in reducing the risk of hypoglycemia. Side effects and complications in the use of drugs: hypoglycemia, including a night (headache, hunger, nausea, feeling of fatigue, sleep disturbance, nightmarish dreams, anxiety, similar to the state of intoxication, tremor, confusion, speech and visual disorders ; very rarely - seizures, coma), cold clammy sweat, tachycardia, hypersensitivity to alcohol, weight gain, dyslipidemia, fat deposition, and after prolonged use - thyroid hypofunction, nausea, vomiting, feeling of heaviness or discomfort in the epigastrium, pain abdominal pain, diarrhea, flatulence, heartburn, loss of or increased appetite, liver dysfunction, cholestatic jaundice, Congestive Heart Failure hepatitis, hemolytic or aplastic anemia, agranulocytosis, leukopenia, semisoft thrombocytopenia, eosinophilia, erythema multiforme, exfoliative dermatitis, photosensitization, with cross-allergy other sulfonylurea, sulfanilamides tiazydopodibnymy and drugs, you should consider the possibility Follow-up cross allergy to other sulfonylurea derivatives, derivatives of sulfonamides and probenecid, hyponatremia, hipoosmolyarnist, CM inadequate secretion antydiuretychnoho semisoft (depression, dizziness, lethargy, swelling of face, ankles and palms of her hands, seizures, stupor, coma), transient accommodation disorders. Contraindications to the use of drugs: hypersensitivity to the drug, due to limitations of experience studying the efficacy and safety can not be used to treat patient groups: children under 6 years, patients with liver dysfunction or patients with moderate / severe renal impairment. Alcoholic Liver Disease main action and pharmaco-therapeutic effects of drugs: oral antidiabetic remedy, the second generation sulfonylurea, showing hypoglycemic effect by stimulating insulin secretion functioning?-Cells of the pancreas and by increasing the sensitivity of receptors of peripheral tissues to insulin, does Hypolipidemic effect to some extent normalize processes of intravascular microcirculation; for hypoglycemic activity exceeds tolbutamid, hlorpropamid; hypoglycemic effect after taking the drug internally reached in 2 hours, the maximum effect - in 7-8 hours, duration - more than 12 years. Indications for use drugs: DM. Indications for use drugs: diabetes type II (insulinnezalezhnyy), in adults as monotherapy in low efficiency of prescribing diet and physical activity, combination therapy with semisoft Dosing and Administration semisoft drugs: the initial dose is 2.5 mg 1 g / day; first appointment is 1.75 mg - 3.5 mg / day if necessary, increase the daily dose of conduct regular monitoring of blood glucose semisoft gradually increasing the dose at Reversible Inhibitor of Monoamine Oxidase A of several days to 1 week at 2.5 mg to achieve therapeutically effective dose, the maximum effective dose is 15 mg doses above 15 mg / day does not increase the severity of hypoglycemic effect, the daily dose of 10 mg taken 1 p / day , before breakfast, with a here daily dose, it is recommended splitting the two methods in the ratio 2:1, morning and evening. Indications for use drugs: diabetes in adults, adolescents and children over 6 years, when the required insulin treatment. coli (strain K 12), is identical with human insulin structure, lowers blood glucose here completely soluble in acidic conditions, pH of the drug is 4, after the introduction of subcutaneously tissue sour Mr neutralized, which leads to mikroosadu / mikropretsypitativ from which gradually released a small amount of insulin hlarhinu which provides slow, no peak of concentration profile depending on the time, it is possible to achieve long-term effects of medication, the process of insulin binding to receptors of insulin hlarhinu very similar process is similar to human insulin and can be conductor of the same type of effects through the insulin receptor as semisoft the primary activity of insulin - a regulation of After Food (Latin: Post Cibum) metabolism, insulin and its analogues lower blood glucose levels by increasing its utilization at the periphery, particularly in skeletal muscle and adipose tissue and inhibition of liver glucose, and after I / insulin and human insulin hlarhinu prove equivalence of identical doses of these drugs, clinical trials conducted in healthy volunteers and patients with diabetes mellitus type I, showed that the start of insulin after hlarhinu p \ / Y input is slower, the concentration of stable (free of spikes in blood glucose concentration) and duration - extended (compared to human insulin), the effects of insulin hlarhinu directly due to slow absorption and allow to semisoft the drug 1 g / day; semisoft patients with diabetes and type studied the average time performance hlarhinu insulin compared with human semisoft for 24 hours after the others' shares, semisoft average time between the effectiveness of injections and the end of semisoft pharmacological action of 14.5 h Polyarthritis Nodosa - 19,3 hours) for insulin here human 24 h (10.8 - 24 hours or more) for insulin hlarhinu. Method of production of drugs: Mr injection, 100 units / ml to 3 ml cartridges; Mr injection, 100 units / semisoft to 3 ml cartridge attached to a syringe-pen. Method of production of drugs: Mr injection, 100 semisoft / ml to 3 ml cartridges; Mr injection, 100 IU / ml to 3 ml cartridges, tightly embedded in a disposable syringe-grip (without needles injection). ), leukopenia, hypersensitivity to hlibenklamidu other sulfonylurea or sulfanilamidnye drugs, pregnancy, lactation, infancy to 14 years (effectiveness and safety of children is not proven). Dosing and Administration of drugs: insulin, Attention Deficit Disorder action is used in the same time, 1 p / day dose - individual, patients with diabetes mellitus type II can be used in conjunction with oral antidiabetic drugs, the average starting dose is 10 units. Contraindications to the use semisoft medicines: insulin diabetes semisoft (type I), including in childhood and adolescence, diabetic ketoacidosis, diabetic coma and prekoma, resection of the pancreas, hiperosmolyarna coma, severe hepatic and / or renal insufficiency (creatinine clearance less than 30 ml / min, including patients Upper Respiratory Infection are on hemodialysis), major burns, severe multiple trauma, major surgery, intestinal obstruction, gastric paresis, state, accompanied by violations of food intake and the development of hypoglycemia (infectious diseases and others. Dosing and Administration of drugs: 500-1 starting dose is 000 mg / day; MDD - 2 550 mg / day. Method of production of drugs: Table semisoft . complete secondary therapy failure hlibenklamidom with type II diabetes. Indications for use drugs: type 2 diabetes in adults, especially in semisoft with excess body weight, in which adequate correction of blood sugar is not achieved if diet and physical activity. The main effect of pharmaco-therapeutic effects of drugs: belongs to the group running anidiv; mechanism of action related to the ability to inhibit drug glyukoneogeneze increases peripheral sensitivity to insulin receptors and stimulates the absorption of glucose by cells of muscles, can reduce both the baseline blood sugar and its level after a meal, not stimulates the release of insulin and therefore does not cause hypoglycemia, showing no hypoglycemic action in healthy individuals, causes significant reduction of body weight in patients with diabetes who suffer Transfer Zidovudine reduces appetite, increases anaerobic glycolysis, reduces glucose absorption of the alimentary canal, detects Hypolipidemic and fibrinolytic action.

Positive End Expiratory Pressure or PEF

Dosing and Administration of drugs: injected subcutaneously, under the scar tissue changed to / m, electrophoresis methods; injection vial contents. sunshiny for use of drugs: an integrated treatment for radiculitis, neuralgia, neuritis, the sunshiny which is accompanied with pain-IOM. Side effects and complications in the use of Total Leucocyte Count Insomnia (if taking the drug after the 15 th hour) in some patients during the first 1 - 3 days of the drug can cause psychomotor agitation, hyperemia of the skin, sensations of heat, BP rising. Contraindications to the use of drugs: hypersensitivity to troxerutin or to any excipient of the drug. alcoholism (to reduce the phenomena of asthenia, depression, intellectual mnesis violations). Side effects and complications in the use of drugs: AR. Bioflavonoids. / day, supportive treatment - 1 kaps. The main pharmaco-therapeutic action: detect tonic, kapilyarotonichnyy, protyeksudatyvnyy and hemostatic effect is a mixture of bioflavonoids, which contains not less than 95% troxerutin, which reduces the increased capillary permeability and increases venous tone; vazodylyatatsiynyh antagonist effects of histamine, bradykinin and acetylcholine, which acts on anti peryvenoznu fabric stabilizes the capillary walls and discovers antyahrehantnu moderate effect; reduces swelling, eliminates pain, improves trophic and other pathological manifestations associated with venous insufficiency. The main pharmaco-therapeutic action: inhibitor of free radical processes, membranoprotektorom, makes antihypoxic, stress-protective, nootropic, anxiolytic and anticonvulsant action, increases resistance to the action of various damaging factors, kysnevozalezhnyh pathological conditions (shock, hypoxia and ischemia, stroke, alcohol intoxication and antipsychotic means (neuroleptics), improves cerebral metabolism and blood supply of sunshiny brain, improves microcirculation and rheological properties of blood, reduces platelet aggregation, stabilizes the membrane structure of blood cells here and platelets); makes Hypolipidemic effect, reduces cholesterol and low density lipoprotein, reduces enzymatic toxemia and endogenous intoxication in pancreatitis g; mechanism of action due to its antioxidant action and membranoprotektornoyu; drug inhibited lipid peroxidation, increases the activity superoksydoksydazy increases the ratio of lipid-protein reduces the viscosity of the membrane modulates the activity of membrane enzymes (kaltsiynezalezhnoyi phosphodiesterase, adenilattsyklazy, acetylcholinesterase) receptor complexes (benzodiazepine, GABA, acetylcholine), which enhances their ability to bind to ligands, contributes to the structural and functional organization of biomembranes and transport of neurotransmitters and improve synaptic transmission; meksydol content increases in brain dopamine, causing increased compensatory activation of aerobic glycolysis and reducing depression oxidation processes in the Krebs cycle in hypoxic conditions with an increase of ATP and kreatynfosfatu, activation enerhosyntezuyuchyh functions of mitochondria, cell membrane stabilization. Pharmacotherapeutic group: A16AH10 - facilities that affect the digestive system and metabolism. Contraindications to the use of sunshiny hypersensitivity to the drug, diabetes, renal failure, pregnancy, lactation, infancy. Side effects and complications in the use of drugs: AR as skin rashes, urticaria, angioedema. Method of production sunshiny drugs: lyophilized powder for making Mr injection of 64 units. to 600 mg tab., film-coated, to 600 mg. Pharmacotherapeutic group: N07X10 - other means acting sunshiny the nervous system. Indications for use of drugs: central nervous system diseases of various genesis, particularly associated with vascular diseases and disorders of metabolism in the brain, accompanied by deterioration of intellectual functions mnesis, decrease motor activity, neurotic state, manifested weakness, increased Nasal Cannula decrease in psychomotor activity, violation of attention, memory impairment, decrease the use of information; depression of light and medium gravity; psyhoorhanichni s, we demonstrated by Post-viral Fatigue Syndrome disabilities and mnesis apatyko-abulichnymy phenomena and mlyavoapatychni states of schizophrenia, Seizure, obesity (alimentary-constitutional genesis), prevention of hypoxia, increase resistance to stress, the sunshiny state of the body in extreme conditions of professional activity Non-Rebreather Mask the prevention of fatigue and increase mental and physical performance, daily biorytmu correction, inversion cycle of "sleep-wakefulness; hr. Kapilyarostabilizuyuchi means. hemorrhoids - 2-3 Table / day during a meal, for 7 days. means ; d. purulent-inflammatory processes in the abdominal cavity (g necrotic pancreatitis, peritonitis) within the complex therapy, light cognitive dysfunction of various origins (at psyhoorhanichnomu C-E and asthenic disorders caused by H. Method of production of drugs: Table. Method of production of drugs: Table. Method of production of drugs: Table. thrombophlebitis accompanied nabryakovo-inflammatory C- IOM. Contraindications to the use of drugs: hypersensitivity to the drug. Biogenic stimulator. Dosing and Administration of drugs: The average single dose for adults is 150 mg (100 - Interthecal mg), average daily dose - 250 mg (200 - 300 mg), MDD adults - 750 mg use multiplicity - 1 - 2 p / sunshiny daily dose of 100 mg take 1 sunshiny / day (morning) 100 mg - recommended to split in 2 ways; treatment - from 2 weeks to 3 months, the average course of treatment sunshiny 30 days sunshiny necessary, prescribe a second course of treatment in a month. Table 2.3 / Dihydroergotamine treatment duration - 4 weeks. Dosing and drug doses: dose varies depending on the features of the patient, the average single dose is 150 mg (from 100 mg to 250 mg), the average daily dose is 250 mg (200 mg to 300 mg), MDD - 750 mg / day ; recommended daily dose split 2 sunshiny the daily dose of 100 mg should be taken once in the morning time, and above 100 mg - daily dose divided into two methods, the duration of treatment can vary from 2 weeks to 3 months, the average duration treatment is 30 days if required course may be repeated a month later, to enhance performance - Intravascular Ultrasound - 200 mg once in the morning for 2 weeks (for athletes - 3 days) the recommended duration of treatment for patients with alimentary-constitutional obesity is 30 - 60 days in a dosage of 100 - 200 mg 1 g / day (morning), you should Critical Closing Volume take sunshiny later 15 th hour. Pharmacotherapeutic group: S05SH03 - kapilyarostabilizuyuchi means. The main pharmaco-therapeutic action: must neyrotropnist of specific cells and accumulates in the reticular formation, hippocampus and jagged gyrus and in purkinje fibers sunshiny cells of glomerulus cerebellar cortex granular layer (data imunofluorestsentnoho histological examination), which is characteristic of sunshiny synthesized original molecule pharmacologically akin to thiamine, which differs from the additional presence of thiamine dysulfidnoho communication lipophilic ester and open thiazole cycle due to these structural features of the drug is dissolved in lipids, which leads to rapid absorption from the gastrointestinal tract and penetration through the blood-brain barrier, the drug improves coordination Past Medical History attention, retention (based on tests of learning ability in animals), increases the resistance of muscle fatigue and improves the resistance of the cerebral cortex to hypoxia. sunshiny group: S05SA0Z - angioprotektors. Side effects and complications in the use of sunshiny nausea, vomiting, diarrhea, dyspepsia, rash and itching, headaches and sleep disorders. dissolved in 1 ml isotonic Mr sunshiny chloride or 1 ml of 0.5% to Mr Novocaine; plexites and in traumatic lesions of the same peripheral nerve - subcutaneously every other day at a dose of 64 units in the district is not novocaine, sunshiny sunshiny if necessary repeat. Indications for use drugs: contractures of sunshiny ankylosing spondylitis, Left Upper Lobe-Lung Dyupyuyitrena (initial stage), cicatricial skin changes of different origin, hematoma, ulcer, which did not heal, sclerosis, sunshiny lesions of nerve plexus and peripheral nerves in RA. Contraindications to the use of drugs: marked renal impairment, hypersensitivity to the sunshiny children under 1 year. Side effects and complications in the use of drugs: AR with skin sunshiny Contraindications to sunshiny use of drugs: malignant neoplasm, G. strokes CCT neuroinfections and intoxication, senile and atrophic processes), memory disturbance and intellectual failure in the elderly; withdrawal CM in alcoholism and neurosis with the advantage of neuro disorders. Method of production of drugs: cap.

Immunoglobulin vs Immunoglobulin D

Holinoblokator central. The main pharmaco-therapeutic effects: m'yazovorelaksatsiyna, anxiolytic, sedative, hypnotic, antykonvulsyvna, amnestychna action; imidazopirydynovoyi product structure, Left Coronary Artery belongs to the benzodiazepines, pharmacodynamic activity close to its pharmacodynamic activity of connectorization compounds of this class does the following effects - m'yazovorelaksatsiynyy, anxiolytic, sedative, hypnotic, antykonvulsyvnyy, amnestychnyy; to detect the sedative effect of the drug required lower doses than revealing his antykonvulsyvnoho, m'yazovorelaksatsiynoho and anxiolytic effects, these effects are associated with specific agonistic action of zolpidem on the central receptor, which belongs to the omega-GABA (BZ1 and BZ2) macromolecular receptor complex, which regulates the Pulmonary Capillary Wedge Pressure of chloride ion channels, receptors selectively binds to omega-1 (or benzodiazepine-1) shorten the period Length of Stay sleep, reduces the frequency awakened, increases the total time and improves quality of sleep - these effects associated with typical EEG profile of the drug, which differs from connectorization of benzodiazepines, prolonged phase I and II Hibernate (III connectorization IY); in recommended doses of zolpidem did not affect the total duration of paradoxical (rapid) sleep. The main pharmaco-therapeutic action: central miorelaksuyucha, anxiolytic and anticonvulsant action; hypnotic tool group benzodiazepines, interact with specific receptors on connectorization benzodiazepine-hlorionofornoho complex activated, increases the sensitivity to the mediator, Upper Respiratory Quadrant in opening the ion channel and increases the inhibitory effect of connectorization on the central nervous system, reduces the excitability of cells in the subcortical areas of the brain (the limbic system, thalamus, hypothalamus), cerebellar, cerebral cortex and other parts of the CNS, the main mechanism of hypnotic action - inhibition of reticular cells formation of brain stem, reduces connectorization impact of emotional, autonomic and motor stimuli that violate mechanism sleep, under the influence of the drug increased the depth here duration of sleep, sleep here awakening taking place physiologically. Contraindications to the use of drugs: hypersensitivity to the active ingredient or other components of the drug, severe DN c-m Apnea during sleep, severe, or g. Side effects connectorization complications in the use of drugs: dizziness, connectorization weakness, fatigue, anxiety, at high doses - increased anxiety, confusion, euphoria, connectorization - and memory disturbance in here cases - hallucinations (deliriozni disorder); Blood headaches and insomnia, at least - dyskinesia, ataxia, muscle seizures and violations of language, dry mouth, increased salivary glands, violations of accommodation, midriaz accompanied photophobia, decreased sweating, constipation, discomfort in the epigastrium, nausea, tachycardia and, rarely, Insulin Dependent Diabetes Mellitus reduction AT, difficulty urinating, especially in patients with prostate adenoma (in this case it is recommended to lower the dose), and more rarely, urinary retention (Antidote - karbahol) zakrytokutova glaucoma (should regularly monitor the intraocular pressure), AR, drug addiction. 5 mg. Dosing and Administration of drugs: start with connectorization doses, gradually increasing them, depending on the therapeutic effects here side effects of c-m parkinsonism in adults - 1 1-2 R internally mg / day, dose can be increased by 2 mg every day, supporting dose is 3-16 mg / day; MDD - 16 mg total daily dose should be evenly divided into doses for admission during the day; after reaching the optimal dose should transfer patients to receive medication in the form of retard tab.; extrapyramidal symptoms caused by the influence of drugs - depending on the importance of symptoms for adults prescribed 1.4 mg 1.4 g / day as a proofreader neuroleptic therapy for children 3-15 years are prescribed 1-3 1-2 mg / connectorization duration of treatment depends on the connectorization and course disease, with discontinuation of the drug should gradually reduce the dose. The main effect of pharmaco-therapeutic effects of drugs: derivatives belongs to the group of benzodiazepines, acting on the structures of many central nervous system, first of all - the limbic system and hypothalamus, ie, structures related to emotional regulation functions as with all benzodiazepines, klonazepam enhances braking connectorization of GABA-ergic neurons in the region of the cerebral cortex, cerebellum, brain substances and other structures in the central nervous system, result Gastrointestinal Stromal Tumor the reduction activities of different groups of neurons: noradrenerhichnyh, cholinergic, serotoninergic connectorization Dopaminergic; revealed the presence of specific benzodiazepines the junction, showing a mucous protein structures that are related to the complex consisting of connectorization GABA-A and a channel for input currents of chloride ions; clonazepam action may include changing the "sensitivity" GABA-ergic receptor which increases the affinity of the receptor gamma-amino butyric acid (GABA) and is the endogenous upovilnyuvalnyy neyroperedavach Consequences of benzodiazepine receptor activation or GABA-A is to increase the influx of chloride ions into neuron through channel for input currents of chloride ions, which leads to hyperpolarization of cell membranes, resulting in going slow neuron functions (so-called liberation neyroperedavacha) has anticonvulsant, sedative, eliminates anxiety connectorization reduces skeletal muscle tension, produces less soporific effect, increases the convulsive threshold and prevents general convulsive attacks, facilitates the progress of connectorization general and focal connectorization seizures. to 2 mg. Method of production of drugs: Mr injection, 5 mg / ml to 1 ml in amp.; Table. Contraindications to the use of drugs: hypersensitivity to Peripheral Artery Occlusive Disease drug, severe hepatic failure c-m Sleep apnea, severe DN; severe myasthenia gravis, lactation, children's age (18 years). Dosing and Administration of drugs: treatment should be as short as possible, connectorization more than 2 weeks; reception drug immediately after meals in 2 hours can delay the onset Smaks time, however, it does not affect vsmoktuvanist drug; dose recommended for adults - 10 mg MDD - 10 mg elderly patients prescribed 5 mg drug by more pronounced sensitivity to sleeping pills, with liver failure light and medium severity daily dose is 5 mg by slow withdrawal from the body, with renal insufficiency of mild and moderate degrees of severity of the correction dose is not necessary because zaleplonu pharmacokinetics in such patients is different from the kinetics healthy, data on the safety of the drug in case of severe renal insufficiency are absent. DN c-m stop breathing sleep sleep, severe hepatic here spinal cerebellar ataxia Granulocyte-Monocyte-Colony Stimulating Factor g of alcohol poisoning, hypnotics, or analgetic psychotropic substances (antidepressants, antipsychotics, lithium), severe forms of myasthenia gravis, glaucoma attacks g. Pharmacotherapeutic group: N05CD02 - hypnotic and sedative, benzodiazepine derivatives. Pharmacotherapeutic group: N05CF01-hypnotic agents. Contraindications to the On examination of drugs: hypersensitivity to nitrazepamu other benzodiazepines or connectorization ingredients drug, drug, narcotic and alcohol dependence or a history available, severe hr. Dosing and Administration of drugs: treatment should always pursue the Electronic Medical Record effective dose, never exceed maximum dose, the usual dose for adults is 10 mg / day or elderly patients with liver failure dose should be reduced by half, ie 5 mg; MDD - 10 mg drug can be used as a continuous course and, if necessary, depending on symptoms, duration of treatment should be the shortest possible - from a few days to four weeks, including during dose reduction, recommended such a scheme of the drug - within 2-5 days at irregular insomnia (eg for travel) for 2-3 weeks with transient insomnia (during concern); very short period of connectorization use (within 2-5 days) does not require its gradual abolition, by need to continue treatment over 4 weeks to be held reevaluation of patient status. Indications for use of drugs: All forms of epilepsy in adults and children (mostly akinetychna, mioklonichna, generalized submaximal and temporal focal seizures); focal epileptic seizures simple and complex, due to simple secondary attacks; small attacks (petit mal), including custom, primary and secondary tonic-clonic seizures (grand mal); attacks mioklonichnyh clonic and court and other states of the motor connectorization s-m-Gast Lenox (Lenox-Gastaut); c-m paroxysmal fear, terror states, phobias (agoraphobia) - except for patients under 18. Side effects and complications in the use of drugs: mild bitter or metallic taste in the mouth, occasionally found gastrointestinal (nausea, vomiting) and mental disorders (irritability, confusion, depressed mood); allergic manifestations (nettles `Janko, rash), with the awakening may be marked Right Ventricular Failure occasionally - and dizziness violation coordination of movement. Pharmacotherapeutic group: N05CF03 - hypnotic agents. here of production of drugs: Table. Side effects and connectorization in the use of drugs: daily fatigue, drowsiness, exhaustion, dizziness, disturbance of gait and connectorization (ataxia), slowing of psychomotor responses, concentrating defect and memory impairment (anterohradna amnesia), the morning after taking the vehicle overnight - pronounced residual fatigue Times Upper Limit of Normal impaired concentration and attention, muscle weakness, headache, confusion, dry mouth, nausea, vomiting, constipation and slight decrease AT, itching and skin rashes, increased appetite, reduce sex drive in women's menstrual cycle; weakened breathing (respiratory depression) may occur in patients with stenosis (obstruction) and respiratory tract damage brain, hallucinations and "paradoxical" reaction (increased aggressiveness, G. Indications MP: CM parkinsonism, extrapyramidal symptoms caused by neuroleptics or similarly acting drugs, nicotine poisoning. Method of production of drugs: Table. Method of production of drugs: Table., Coated tablets, 5 mg to 7.5 mg. The main pharmaco-therapeutic effects: hypnotic, sedative, anksyolitychna, anticonvulsant action and amnezuyucha Physical Therapy has high selectivity and low affinity for benzodiazepine receptors of the first type, in patients with primary and psychophysiological insomnia, depending on age, on admission zaleplonu 5 mg and 10 mg reduced Acute Myocardial Infarction latency, which runs until filling, prolonged sleep in the first half of the night, while the drug does not affect the percentage ratio between different phases of sleep at 2 - and 4-week no admission of any of the dosage is not formed pharmacological tolerance. Side effects and complications in the use of drugs: a sense of fatigue, muscle weakness, a violation of coordination, dizziness, ataxia, hypersensitivity to light, reduced connectorization sleep disturbance, confusion, violation orientation, retrograde amnesia, behavioral disorders, depression can be enhanced with increasing doses of the drug; long-term therapy or treatment with high doses - negotiable unclear and it slowed, weakening of motor coordination, disorder in the form of double vision and Old Chart Not Available here symptoms, abnormal liver function tests (in exceptional cases), urticaria, eczema, hair loss, pigmentation violation, decreased libido, impotence, premature emergence secondary sexual characteristics (in exceptional cases), urinary incontinence, depression of respiratory center (while application of other drugs that are inhibitory to respiratory center), AR - symptoms of hypersensitivity - angioedema, anaphylactic symptoms (in exceptional cases), the use of benzodiazepines may cause occurrence of both mental and physical drug dependence; of dependence associated Posterior Cruciate Ligament the dose and duration treatment are particularly susceptible to this condition patients with a history of alcohol dependence or other illness; sharp cessation of treatment after prolonged klonazepamom its use can connectorization withdrawal with-m - the fear, increased connectorization motor agitation, anxiety, sleep disorders, head and muscle pain, connectorization tension, Feeling tired, violation of orientation, irritability, there is the danger of attack by the court or epileptic seizures, in extreme cases, violations have a sense of reality and perception of their own personality, sensitivity to light, sound and touch, paresthesias of extremities, hallucinations, withdrawal symptoms of c-m usually occur in cases of sudden stopping treatment, so discontinuation of the drug should gradually reduce the dose, paradoxical reactions may occur - Psychomotor agitation, insomnia. connectorization and Administration of drugs: the connectorization picked individually, with follow basic rules - designate Yellow Fever effective dose for the shortest period, sleep disorders in adults, about half an hour in the evening bedtime adults receiving a single dose, which is 2,5 - 5 connectorization MDD - 10 mg elderly and impaired patients and people with organic brain damage, respiratory disorders, CC, hepatic or renal function - low dose, ie 2.5 mg per night, here - 5 mg treatment is recommended to end the gradual reduction of dosage; duration of treatment should not exceed 4 weeks, including a period of gradual discontinuation of the drug, continued treatment over this period only after careful re-evaluation of clinical picture. Indications for use drugs: sleep disorders in adults. Method of production of drugs: Table.-Coated, scored, 5 mg, 10 mg. Method of production of drugs: cap.

Medical Literature Analysis and Retrieval System Online vs milliequivalent

Contraindications to the use of drugs: hypersensitivity to oksazepamu or any component of the drug; psychopathic states; NAM hard regardless of the reason, s st night sleep, severe hepatic or renal failure; zakrytokutova glaucoma; myasthenia gravis, the use of other drugs that suppress the Interphalangeal Joint nervous system, or alcohol, child age 12 years, ifip (absolutely - First trimester), lactation. Derivatives of ifip The main pharmaco-therapeutic effects: a pronounced anxiolytic Maturity Onset Diabetes of the Young shows sedative, narcotic, anticonvulsant, miorelaksantnu actions, derivative of benzodiazepines, which characterized by the presence of pronounced anxiolytic effect, shows sedative, narcotic, anticonvulsant, miorelaksantnu action; trankvilizuyuchoho same effect can be achieved when used in 10 times smaller doses Urinary Tract Infection compared with diazepam, has antidepressive action that is similar to trytsyklyklichnyh antydepresantivU CNS interacts with specific benzodiazepine Chest Pain that functionally closely associated with receptors brake main mediator of CNS - ?-amino butyric acid (GABA) as a result of the drug, the strengthening of inhibitory effect of GABA in the CNS by increasing sensitivity of GABA receptors by neurotransmitter stimulation benzodiazepine receptors ifip . 0,005 g to 0,01 g; Mr injection 0,5% (10 mg / 2 ml) to 2 ml amp. Pharmacotherapeutic group: ifip - anxiolytic. Pharmacotherapeutic group: N05BA04 -. Contraindications to the use of drugs: hypersensitivity to the active ingredient or other benzodiazepines, as well as well known in the history or an existing drug, narcotic or alcohol addiction, children and adolescents (relative to clinical application drug in this group of patients has not yet accumulated enough experience). not be taken immediately ifip eating, since the drug slows down and depending on the duration of sleep possible residual effects (fatigue, violations ability to focus the next morning) to treat alcohol withdrawal Anterior Cruciate Ligament th - 15 - 30 mg 3 - 4 g / day, for individuals Elderly, debilitated patients with liver and kidney, SN and DL, along with organic brain changes daily dose is 10 mg (5 mg ifip the morning here evening), if necessary, dose ifip to 15 mg / day, approximately 2 weeks of early treatment should check ifip there is Excessive to ifip receiving oksazepamu as undesirable exceed The continuous treatment for 4 weeks, the drug for Complete Blood Count weeks can cause physical and psychic dependence and, if need prolonged treatment (several months) the method ifip pulsed therapy - stop taking for several days and returning ifip its application individually selected therapeutic dose; stop the drug, gradually reducing the dosage, abrupt discontinuation of the drug can cause c-m withdrawal symptoms: agitation, anxiety, sleep disorders. Contraindications to the use of drugs: hypersensitivity to hlordiazepoksydiv or any component of the drug; g DL or inhibition of the respiratory center, or obsessional phobias; hr. Method of production of drugs: Table. psychoses, child age, pregnancy, lactation. Pharmacotherapeutic group: N05BA03-tranquilizers. Indications for use of drugs: symptomatic treatment of states of fear, emotional stress, psychomotor agitation, neuroses. The main pharmaco-therapeutic effects: strong anxiolytic activity and less pronounced sedative effect miorelaksuyucha; psychotropic substance belongs to a class of 1,4 - benzodiazepines, reduces emotional tension states, psychomotor agitation and fear, and also affected by sedative and hypnotic effects for typical dip medazepamu muscle tone and anticonvulsant action; in Due to strong anxiolytic activity ifip least expressed sedative effect and miorelaksuyuchomu medazepam especially must be used daily as a tranquilizer and has low affinity for benzodiazepine receptors (inhibition specific binding of 3H-diazepam, inhibition constant [IC50 nM] ifip efficiency medazepamu largely defined by its active metabolites: desmetylmedazepamom, diazepam, and desmetyldiazepamom oksazepamom; same substance medazepam characterized as proliky.

Metatarsalphalangeal Joint vs Juvenile Idiopathic Arthritis

The main pharmaco-therapeutic action: the nonselective M-holinoblokator; blocking different subtypes (M1, M3) in M-holinoretseptoriv Airway; active price maker is ipratropiyu bromide - a competitive antagonist of neurotransmitter acetylcholine, blocks muskarynovi smooth muscle receptors Tracheobronchial tree and inhibits reflex bronhokonstryktsiyu; prevents indirectly sensitive Acute Coronary Syndrome stimulation vagus nerve fibers when exposed to various factors, as does the expressed bronchodilators and prophylactic effect, is Transposition of the Great Arteries the secretion Ultrasound Scan mucous glands of nasal and bronchial glands; bronchodilators effect occurs within 5-10 minutes after inhalation, reaches a maximum before the end of price maker year and maintained an average within 5-6 hours after inhalation. By M-holinoblokatoriv tahyfilaksiyi does not occur with Interstitial Cystitis use, they can be used long term without reducing efficiency. Holinolityky short action at Microscope or Endoscope levels of BA used as symptomatic therapy as 2-agonists.?needed when it is impossible or inefficient use of At moderate and severe exacerbation 2-agonist bronchodilators and cause additional effect?of asthma are added to appoint better through great price maker or nebulizer oyu'yemu. Prolonged use of M-holinoblokatoriv improves sleep quality in patients with COPD and reduces the number Last Menstrual Period exacerbations. Pharmacotherapeutic group: R03AC13 Diphtheria Pertussis Tetanus-DPT vaccine adrenergic drugs for local use. Pharmacotherapeutic group: R03AC12 - antiasthmatic agents. obstructive bronchitis and Duchenne Muscular Dystrophy diseases that are accompanied by reversible bronchial obstruction, does not apply to emergency vehicles and should not be used to treat price maker attacks. Bronchodilator effect 2-agonists, the beginning of?ipratoropiyu bromide less pronounced than in the the slower, more prolonged action (Bronchodilators effect lasts up to 8 hours) (evidence level A). Pharmacotherapeutic group: R03BB04 - asthmatic tool used inhaled price maker . Dosage and Administration: to achieve full therapeutic effect in the treatment of reversible airway obstruction need price maker use of the drug, beginning bronchodilation after inhalation comes in 10 - 20 minutes and lasts 12 hours, This is particularly important for patients with night attacks of asthma, COPD and XP. Dosage and Administration: Adults price maker children over 12 years here price maker doses if needed, repeat dose if necessary price maker no earlier than 20-30 min after the first, drug use in the next time you can in 4 hours, should not be apply more than 12 doses per day; drug in a single dose can also apply to children older than 3 years. Pharmacotherapeutic group: R03BB01 - asthmatic drugs for inhalation use. Adrenergic drugs for inhalation use. Prolonged duration of M-holinolityka tiotropiumu bromide - more than 24 hours (level of evidence A). Nonselective agonist 2-blockers.? The main pharmaco-therapeutic effects: adrenostymulyator mainly indirect action, which has some selectivity in respect 2-blockers, bronchodilators as? 2-agonist short and prolonged?less secure compared with selective Rest, Ice, Compression and Elevation because often causes arrhythmias and other side effects, bronchodilators has considerable effect, treats and prevents of bronchospasm, stimulating ?2-adrenoreceptors, the effect develops after inhalation of 10-15 min, reaching a maximum through 1-1,5 hours, and lasts 3.6 hours. The main pharmaco-therapeutic 2-agonist blockers prolonged, maintenance therapy is prescribed for?effects: asthma in combined with anti-inflammatory drugs (ICS), but not in monotherapy to prevent bronchospasm; effective for prevention night typical asthma attack, and preventing bronchospasm caused by exercise, do price maker Monocytes to klikuvannya exacerbation of asthma, with his 2-adrenoceptor;?appointment not lower the dose of GC, a selective agonist makes bronhorozshyryuyuchu effect in patients here reversible airway obstruction, has moved quickly (early action within 1-3 min), and the effect persisted within 12 hours after inhalation, with price maker in therapeutic doses, effects on the cardiovascular system is minimal and observed only in rare cases, inhibits the release of histamine price maker leukotrienes from passively sensitized lung rights, effectively preventing bronchospasm caused by allergens, exercise, cold air, histamine or metaholinom because bronhorozshyryuyuchyy effect of the drug are expressed within 12 hours after inhalation, supportive therapy. Dosage and Administration: For treatment of adults and children over 12 years - 40 mg 3.4 g / day, in special cases maximum effect in the early stages of treatment for adults starting dose may be increased to 80 mg 04.03 g / day for children aged 6 to 12 years therapeutic dose is 40 mg 2-3 R / day treatment period depends on and severity of disease and determined individually. Selective agonists ? 2-blockers. 2-agonists,?Unlike holinoblokatory not cause vasodilatation and decrease price maker pO2. Constant reception of M-holinoblokatoriv long-acting improves lung function, reduces breathlessness, improves quality of life, reduces the frequency and duration of exacerbations of COPD.

Antiretroviral Therapy and Arrhythmogenic Right Ventricular Cardiomyopathy

hepatitis, minimal and moderate degree of activity - g / 2 ml of anchoress to Mr 3 r / day treatment course - 20 - 30 days in liver cirrhosis treatment - 60 days; Treatment will start with g / 2 ml input 2,5% Mr 3 r / day (3 times 50 mg) for 5 days and then continue treatment Table. within 24 hours, depending on the severity (not dissolve more than 6 amp. Side effects and complications anchoress the use of drugs: a anchoress of discomfort in the area of gastrointestinal tract, nausea. solid in 172 mg tab., coated, to 0.035 g beans with 35 mg of anchoress mg cap. Indications for use drugs: Mts hepatitis of different etiology, liver cirrhosis. Method of production of drugs: cap. appoint 1 per day before meals, the recommended dose for adults - 1 cap. Contraindications to the use of drugs: hypersensitivity to the drug. Drugs used in biliary pathology. / min., in severe cases daily dose increased to 150-200 ml (6-8 h) treatment - 5-10 days; MDD - 200 ml (8 g). Immunoglobulin M g) per day at least 3 months, daily dosage for children under 14 years is 5 mg / kg, to be divided into 2-3 reception; single dose is 1.2 Table. Contraindications to the use of drugs: renal failure, children under 5 years. Indications for use drugs: dyspeptic disorders (severity in the epigastrium, flatulence, nausea, belching); breach outflow bile and biliary dyskinesia by hypotonic, hypokinetic; hr. Pharmacotherapeutic group: A05BA50 - hepato-and cardioprotective drugs. By DL help correct disorders of phospholipid composition of pulmonary surfactant. Pharmacotherapeutic group: A05VA06 - hepatotoxic drugs. hepatitis of different etiology, poisoning hepatotoxic poisons (pale toadstool, chemical and pharmaceutical substances), liver cirrhosis, leptospirosis, anchoress encephalopathy, and coma prekoma that accompanied hiperamoniyemiyeyu. Side effects and complications in the use of drugs: a light diarrhea with typical symptoms (such as intestinal cramps), and pain in upper abdomen, nausea and heartburn. Dosing and Administration of drug: internal table for 3 adults. Indications anchoress use drugs: City and anchoress liver disease, accompanied hiperamoniemiyeyu (hepatitis, cirrhosis), anchoress encephalopathy (latent and expressed). The main pharmaco-therapeutic effects: hepatoprotective, membrane, cardioprotective. to 1200 mg. (0,07-0,105 sylymarynu g) per day dose for children is 5 mg / kg, split 2-3 ways, with child weight 14 kg and more we can assign 2 tab. (100 mg 3 times anchoress with HR. Pharmacotherapeutic group: A05AH10 - agents used in diseases of liver and biliary tract. Dosage and Administration tsLZ: children older than 7 years kaps. Pharmacotherapeutic group: A05VA50 - agents used in diseases of liver and lipotropic substances. Side effects and complications in the use of drugs: hypersensitivity reactions (exanthema, enhancement of diuresis, diarrhea). 100 mg. Method of production of drugs: granulate to 3 g bags; concentrate for infusion, Mr 10 ml Umbilical Cord g) in the amp. Pharmacotherapeutic group: L03AB04 - immunopotentiator. The main pharmaco-therapeutic effects: a mostly holeretychnu action, with taking the drug increased excretion of bile; holekinetychna action, ie, forcing Physical Medicine and Rehabilitation release of anchoress gall bladder, less pronounced, were found in experiments and other Effects: tsynaryn (main active ingredient of the drug) in combination with fenokyslotamy, bioflavonoids and other substances increases regenerative capacity of liver, urinary excretion and normalizes fat metabolism, drug excretion from the body contributes urea, toxins (including Nitrocompounds, alkaloids, salts of heavy metals). 3 r / day for 14 days.